doi:10.1016/S0021-9258(18)73482-0
2,3 In addition to their obvious efficacy and benefits, GLP-1s have been associated with various side effects and nutritional gaps for which patients may require additional support
doi:10.3390/ijms23052717 Bigio B, Azam S, Math AA, Nasca C
A meta-analysis has revealed how GLP1 agonists provide a similar degree of glycaemic control to that achieved following bariatric surgery Glucagon-like peptide-1 (GLP1) receptor agonists seem to give rise to the same level of glycaemic control as that achieved following bariatric surgery but the latter still confers the highest reductions in weight according to a systematic review and meta-analysis by researchers from Ontario, Canada
Semaglutide activates GLP-1 receptors that slow gastric motility, meaning food remains in your stomach longer
Get BPC-157 from LIVV Natural after consulting your doctor